Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;11(5):374-83.
doi: 10.1038/gene.2010.31. Epub 2010 Jun 10.

Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis

Affiliations

Evidence for associations between the purinergic receptor P2X(7) (P2RX7) and toxoplasmosis

S E Jamieson et al. Genes Immun. 2010 Jul.

Abstract

Congenital Toxoplasma gondii infection can result in intracranial calcification, hydrocephalus and retinochoroiditis. Acquired infection is commonly associated with ocular disease. Pathology is characterized by strong proinflammatory responses. Ligation of ATP by purinergic receptor P2X(7), encoded by P2RX7, stimulates proinflammatory cytokines and can lead directly to killing of intracellular pathogens. To determine whether P2X(7) has a role in susceptibility to congenital toxoplasmosis, we examined polymorphisms at P2RX7 in 149 child/parent trios from North America. We found association (FBAT Z-scores +/-2.429; P=0.015) between the derived C(+)G(-) allele (f=0.68; OR=2.06; 95% CI: 1.14-3.75) at single-nucleotide polymorphism (SNP) rs1718119 (1068T>C; Thr-348-Ala), and a second synonymous variant rs1621388 in linkage disequilibrium with it, and clinical signs of disease per se. Analysis of clinical subgroups showed no association with hydrocephalus, with effect sizes for associations with retinal disease and brain calcifications enhanced (OR=3.0-4.25; 0.004<P<0.009) when hydrocephalus was removed from the analysis. Association with toxoplasmic retinochoroiditis was replicated (FBAT Z-scores +/-3.089; P=0.002) in a small family-based study (60 families; 68 affected offspring) of acquired infection in Brazil, where the ancestral T(+) allele (f=0.296) at SNP rs1718119 was strongly protective (OR=0.27; 95% CI: 0.09-0.80).

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Haploview analysis for D’ and r2 pairwise measures of LD between P2RX7 SNPs in unrelated family founders for (a) NCCCTS and (b) Brazil. D’ values and confidence levels (LOD) are represented as bright red for D’=1, LOD≥2; blue for D’=1, LOD<2; white for D’<1, LOD<2. r2 values are represent as black for r2=1, white for r2=0, with intermediate values for 0<r2<1 indicated by shades of grey. The numbers within the squares represent the D’ or r2 scores for pairwise LD.

References

    1. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, Roizen N, et al. Outcome of treatment for congenital toxoplasmosis, 1981–2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis. 2006;42:1383–1394. - PubMed
    1. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis. 1994;18:38–72. - PubMed
    1. McLeod R, Kieffer F, Sautter M, Hosten T, Pelloux H. Why prevent, diagnose and treat congenital toxoplasmosis? Mem Inst Oswaldo Cruz. 2009;104:320–344. - PMC - PubMed
    1. Desmonts G, Couvreur J. [Congenital toxoplasmosis. Prospective study of the outcome of pregnancy in 542 women with toxoplasmosis acquired during pregnancy] Ann Pediatr (Paris) 1984;31:805–809. - PubMed
    1. Remington JS, McLeod R, Thullie P, Desmonts G. Toxoplasmosis. In: Remington JS, Baker C, Wilson E, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 6th Ed. Philadelphia: WB Saunders; 2005. pp. 947–1091.

Publication types

MeSH terms

Substances